Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
Immunogenetics
|
January 1, 1995
Polymorphism of the MHC class II Eb gene determines the protection against collagen-induced arthritis
M A Gonzalez-Gay, E Zanelli, C J Krco, et al.
Human Immunology
|
February 23, 1999
HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis
I E van der Horst-Bruinsma, H Visser, J M Hazes, et al.
Human Immunology
|
September 15, 1996
Human leukocyte antigen-DRB1*1502 (DR2Dw12) transgene reduces incidence and severity of arthritis in mice
M A Gonzalez-Gay, E Zanelli, S D Khare, et al.
Genes and Immunity
|
November 13, 2001
Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF-308A in systemic lupus erythematosus
M W van der Linden, A R van der Slik, E Zanelli, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 2, 1998
Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice
A Geluk, V Taneja, K E van Meijgaarden, et al.
The Journal of Experimental Medicine
|
October 1, 1994
Protective role of major histocompatibility complex class II Ebd transgene on collagen-induced arthritis
M A Gonzalez-Gay, G H Nabozny, M J Bull, et al.
Immunogenetics
|
November 3, 1998
An extended HLA-DQ-DR haplotype rather than DRB1 alone contributes to RA predisposition
E Zanelli, T W Huizinga, P A Guerne, et al.
Rheumatology (Oxford, England)
|
March 21, 2001
Evidence for a protective role of the human leukocyte antigen class II region in early rheumatoid arthritis
K Vos, I E van der Horst-Bruinsma, J M Hazes, et al.
Journal of Neuroimmunology
|
May 15, 2010
Results of a phase I study in patients suffering from secondary-progressive multiple sclerosis demonstrating the safety of the amino acid copolymer PI-2301 and a possible induction of an anti-inflammatory cytokine response
J Kovalchin, J Krieger, M Genova, et al.
Neurology
|
August 28, 2002
Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region
B A de Jong, T W J Huizinga, E Zanelli, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
Immunogenetics
|
January 1, 1995
Polymorphism of the MHC class II Eb gene determines the protection against collagen-induced arthritis
M A Gonzalez-Gay, E Zanelli, C J Krco, et al.
Human Immunology
|
February 23, 1999
HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis
I E van der Horst-Bruinsma, H Visser, J M Hazes, et al.
Human Immunology
|
September 15, 1996
Human leukocyte antigen-DRB1*1502 (DR2Dw12) transgene reduces incidence and severity of arthritis in mice
M A Gonzalez-Gay, E Zanelli, S D Khare, et al.
Genes and Immunity
|
November 13, 2001
Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF-308A in systemic lupus erythematosus
M W van der Linden, A R van der Slik, E Zanelli, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 2, 1998
Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice
A Geluk, V Taneja, K E van Meijgaarden, et al.
The Journal of Experimental Medicine
|
October 1, 1994
Protective role of major histocompatibility complex class II Ebd transgene on collagen-induced arthritis
M A Gonzalez-Gay, G H Nabozny, M J Bull, et al.
Immunogenetics
|
November 3, 1998
An extended HLA-DQ-DR haplotype rather than DRB1 alone contributes to RA predisposition
E Zanelli, T W Huizinga, P A Guerne, et al.
Rheumatology (Oxford, England)
|
March 21, 2001
Evidence for a protective role of the human leukocyte antigen class II region in early rheumatoid arthritis
K Vos, I E van der Horst-Bruinsma, J M Hazes, et al.
Journal of Neuroimmunology
|
May 15, 2010
Results of a phase I study in patients suffering from secondary-progressive multiple sclerosis demonstrating the safety of the amino acid copolymer PI-2301 and a possible induction of an anti-inflammatory cytokine response
J Kovalchin, J Krieger, M Genova, et al.
Neurology
|
August 28, 2002
Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region
B A de Jong, T W J Huizinga, E Zanelli, et al.
Page
of 6